Identification of novel predictive factors for post surgical corneal haze.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 11 2019
Historique:
received: 03 01 2019
accepted: 22 10 2019
entrez: 20 11 2019
pubmed: 20 11 2019
medline: 3 11 2020
Statut: epublish

Résumé

Molecular factors altered in corneas that develop haze post refractive surgery have been described, but pre-existing factors that predispose clinically normal corneas to aberrant fibrosis post surgery and the role of the corneal epithelium remains unknown. We analyzed the global gene expression in epithelium collected intraoperatively from subjects undergoing photorefractive keratectomy. Subjects were grouped into those that developed haze 12 months post surgery (n = 6 eyes; haze predisposed) and those that did not develop haze in a similar follow up duration (n = 11 eyes; controls). Ontological analysis of 1100 upregulated and 1780 downregulated genes in the haze predisposed group revealed alterations in pathways associated with inflammation, wnt signaling, oxidative stress, nerve functions and extra cellular matrix remodeling. Novel factors such as PREX1, WNT3A, SOX17, GABRA1and PXDN were found to be significantly altered in haze predisposed subjects and those with active haze(n = 3), indicating their pro-fibrotic role. PREX1 was significantly upregulated in haze predisposed subjects. Ectopic expression of PREX1 in cultured human corneal epithelial cells enhanced their rate of wound healing while its ablation using shRNA reduced healing compared to matched controls. Recombinant TGFβ treatment in PREX1 overexpressing corneal cells led to enhanced αSMA expression and Vimentin phosphorylation while the converse was true for shPREX1 expressing cells. Our data identify a few novel factors in the corneal epithelium that may define a patient's risk to developing post refractive corneal haze.

Identifiants

pubmed: 31740714
doi: 10.1038/s41598-019-53123-3
pii: 10.1038/s41598-019-53123-3
pmc: PMC6861263
doi:

Substances chimiques

Guanine Nucleotide Exchange Factors 0
PREX1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16980

Références

J Cataract Refract Surg. 2001 Mar;27(3):404-10
pubmed: 11255052
Exp Eye Res. 2006 May;82(5):788-97
pubmed: 16303127
Curr Opin Rheumatol. 2011 Nov;23(6):562-7
pubmed: 21885974
Exp Eye Res. 2015 May;134:33-8
pubmed: 25797478
Am J Ophthalmol. 2003 Sep;136(3):530-6
pubmed: 12967809
Mol Vis. 2017 Feb 26;23:39-51
pubmed: 28275314
Nat Cell Biol. 2010 Aug;12(8):758-67
pubmed: 20622870
Exp Eye Res. 2010 Sep;91(3):456-61
pubmed: 20603114
Exp Eye Res. 2003 Jan;76(1):71-87
pubmed: 12589777
Mol Cancer. 2010 Jul 28;9:200
pubmed: 20667089
Oncotarget. 2016 Aug 9;7(32):51335-51348
pubmed: 27351228
Physiol Genomics. 2010 Mar 3;41(1):71-7
pubmed: 20028935
Oncotarget. 2017 Jan 31;8(5):8559-8573
pubmed: 28051998
Am J Physiol. 1995 Apr;268(4 Pt 1):L565-75
pubmed: 7733299
J Refract Surg. 1995 May-Jun;11(3 Suppl):S309-13
pubmed: 7553113
Cornea. 1997 Mar;16(2):177-87
pubmed: 9071531
Wound Repair Regen. 2005 Jan-Feb;13(1):61-7
pubmed: 15659037
Ophthalmology. 1994 Sep;101(9):1565-74
pubmed: 7522315
Eye (Lond). 2007 Jan;21(1):96-7
pubmed: 16327796
Exp Eye Res. 2008 Feb;86(2):235-40
pubmed: 18068702
Invest Ophthalmol Vis Sci. 2003 May;44(5):1879-87
pubmed: 12714619
Br J Ophthalmol. 2015 Feb;99(2):147-52
pubmed: 25395684
J Ophthalmol. 2014;2014:196827
pubmed: 25105018
J Neurosci. 2011 Sep 28;31(39):13921-35
pubmed: 21957254
Nat Commun. 2011 Nov 22;2:555
pubmed: 22109529
PLoS One. 2009 May 27;4(5):e5711
pubmed: 19479035
Curr Opin Ophthalmol. 2005 Aug;16(4):256-9
pubmed: 16000900
Nat Protoc. 2007;2(2):329-33
pubmed: 17406593
Int J Ophthalmol. 2016 Apr 18;9(4):487-90
pubmed: 27162717
Surv Ophthalmol. 2009 Jul-Aug;54(4):487-502
pubmed: 19539836
Curr Eye Res. 1996 Aug;15(8):824-32
pubmed: 8921225
Invest Ophthalmol Vis Sci. 1999 Aug;40(9):1959-67
pubmed: 10440249
PLoS One. 2017 Mar 3;12(3):e0171712
pubmed: 28257425
Adv Wound Care (New Rochelle). 2013 Jun;2(5):195-214
pubmed: 24527343
Ophthalmology. 2006 Oct;113(10):1798-806
pubmed: 17011958
Invest Ophthalmol Vis Sci. 2011 Feb 03;52(2):651-7
pubmed: 20847116
Invest Ophthalmol Vis Sci. 2013 Nov 15;54(12):7510-21
pubmed: 24130180
Prog Retin Eye Res. 1999 May;18(3):311-56
pubmed: 10192516
Cornea. 2017 Aug;36(8):961-966
pubmed: 28542088
Tohoku J Exp Med. 2010 Sep;222(1):45-50
pubmed: 20814177
Mol Vis. 2015 Jan 12;21:12-25
pubmed: 25593510
Adv Wound Care (New Rochelle). 2013 Jun;2(5):215-224
pubmed: 24527344
J Cataract Refract Surg. 2016 May;42(5):710-6
pubmed: 27255247
Diabetes. 2014 Feb;63(2):715-27
pubmed: 24306208
Sci Rep. 2016 May 13;6:25785
pubmed: 27173636
J Invest Dermatol. 2007 Mar;127(3):526-37
pubmed: 17299435
J Refract Surg. 2001 Nov-Dec;17(6):696-9
pubmed: 11758990
Mol Vis. 2012;18:1107-14
pubmed: 22605922
Physiol Res. 2012;61(4):337-46
pubmed: 22670697
Adv Ther. 2019 Apr;36(4):786-797
pubmed: 30859502
Refract Corneal Surg. 1990 Sep-Oct;6(5):340-5
pubmed: 2257258
Biochem Biophys Res Commun. 2010 Jan 1;391(1):287-92
pubmed: 19913506
Cancer Cell. 2004 Jun;5(6):607-16
pubmed: 15193263
Mol Vis. 2010 Dec 15;16:2727-32
pubmed: 21179238
J Biol Chem. 2005 May 13;280(19):18871-80
pubmed: 15677465
Inflamm Bowel Dis. 2003 Sep;9(5):290-301
pubmed: 14555912
Mol Vis. 2011;17:2283-91
pubmed: 21921979
Biochim Biophys Acta. 2009 Aug;1792(8):746-56
pubmed: 19539753
Am J Pathol. 2009 Aug;175(2):725-35
pubmed: 19590037
Zhonghua Yan Ke Za Zhi. 2006 Oct;42(10):918-24
pubmed: 17217787

Auteurs

Nimisha R Kumar (NR)

GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, India.
Department of Biomedical Sciences, School of Bio Sciences and Technology, VIT, Vellore, India.

Pooja Khamar (P)

Cornea and Refractive Surgery Division, Narayana Nethralaya, Bangalore, India.

Rohit Shetty (R)

Cornea and Refractive Surgery Division, Narayana Nethralaya, Bangalore, India.
Singapore Eye Research Institute, Singapore, Singapore.

Ankit Sharma (A)

Thrombosis Research Institute, Bangalore, India.

Naren Shetty (N)

Cornea and Refractive Surgery Division, Narayana Nethralaya, Bangalore, India.

Natasha Pahuja (N)

Cornea and Refractive Surgery Division, Narayana Nethralaya, Bangalore, India.

Valsala Gopalakrishnan Abilash (VG)

Department of Biomedical Sciences, School of Bio Sciences and Technology, VIT, Vellore, India.

Vishal Jhanji (V)

Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Anuprita Ghosh (A)

GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, India.

Rajiv R Mohan (RR)

Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, 65211, USA.
Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO, 65212, USA.
Harry S Truman Veterans' Memorial Hospital, Columbia, MO, 65201, USA.

Rajani Kanth Vangala (RK)

Thrombosis Research Institute, Bangalore, India.

Arkasubhra Ghosh (A)

GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, India. arkasubhra@narayananethralaya.com.
Singapore Eye Research Institute, Singapore, Singapore. arkasubhra@narayananethralaya.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH